rs930557

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024596.5(MCPH1):​c.940G>C​(p.Asp314His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.789 in 1,613,834 control chromosomes in the GnomAD database, including 511,578 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. D314D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.68 ( 38517 hom., cov: 33)
Exomes 𝑓: 0.80 ( 473061 hom. )

Consequence

MCPH1
NM_024596.5 missense

Scores

3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 0.257

Publications

59 publications found
Variant links:
Genes affected
MCPH1 (HGNC:6954): (microcephalin 1) This gene encodes a DNA damage response protein. The encoded protein may play a role in G2/M checkpoint arrest via maintenance of inhibitory phosphorylation of cyclin-dependent kinase 1. Mutations in this gene have been associated with primary autosomal recessive microcephaly 1 and premature chromosome condensation syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
MCPH1 Gene-Disease associations (from GenCC):
  • microcephaly 1, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • microcephaly with intellectual disability
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary breast carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.8958876E-7).
BP6
Variant 8-6444662-G-C is Benign according to our data. Variant chr8-6444662-G-C is described in ClinVar as Benign. ClinVar VariationId is 21705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCPH1NM_024596.5 linkc.940G>C p.Asp314His missense_variant Exon 8 of 14 ENST00000344683.10 NP_078872.3 Q8NEM0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCPH1ENST00000344683.10 linkc.940G>C p.Asp314His missense_variant Exon 8 of 14 1 NM_024596.5 ENSP00000342924.5 Q8NEM0-1

Frequencies

GnomAD3 genomes
AF:
0.679
AC:
103254
AN:
152040
Hom.:
38511
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.337
Gnomad AMI
AF:
0.853
Gnomad AMR
AF:
0.789
Gnomad ASJ
AF:
0.700
Gnomad EAS
AF:
0.787
Gnomad SAS
AF:
0.746
Gnomad FIN
AF:
0.880
Gnomad MID
AF:
0.646
Gnomad NFE
AF:
0.815
Gnomad OTH
AF:
0.690
GnomAD2 exomes
AF:
0.781
AC:
194302
AN:
248836
AF XY:
0.784
show subpopulations
Gnomad AFR exome
AF:
0.322
Gnomad AMR exome
AF:
0.857
Gnomad ASJ exome
AF:
0.690
Gnomad EAS exome
AF:
0.790
Gnomad FIN exome
AF:
0.887
Gnomad NFE exome
AF:
0.813
Gnomad OTH exome
AF:
0.792
GnomAD4 exome
AF:
0.800
AC:
1169787
AN:
1461676
Hom.:
473061
Cov.:
62
AF XY:
0.800
AC XY:
581625
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.321
AC:
10744
AN:
33474
American (AMR)
AF:
0.849
AC:
37976
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.688
AC:
17988
AN:
26136
East Asian (EAS)
AF:
0.793
AC:
31461
AN:
39698
South Asian (SAS)
AF:
0.755
AC:
65122
AN:
86248
European-Finnish (FIN)
AF:
0.884
AC:
47131
AN:
53296
Middle Eastern (MID)
AF:
0.666
AC:
3839
AN:
5768
European-Non Finnish (NFE)
AF:
0.818
AC:
909236
AN:
1111940
Other (OTH)
AF:
0.766
AC:
46290
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
13472
26944
40416
53888
67360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20836
41672
62508
83344
104180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.679
AC:
103273
AN:
152158
Hom.:
38517
Cov.:
33
AF XY:
0.687
AC XY:
51099
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.336
AC:
13933
AN:
41458
American (AMR)
AF:
0.790
AC:
12079
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.700
AC:
2430
AN:
3470
East Asian (EAS)
AF:
0.788
AC:
4084
AN:
5186
South Asian (SAS)
AF:
0.747
AC:
3601
AN:
4822
European-Finnish (FIN)
AF:
0.880
AC:
9336
AN:
10606
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.815
AC:
55392
AN:
68006
Other (OTH)
AF:
0.692
AC:
1459
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1385
2770
4155
5540
6925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.785
Hom.:
35884
Bravo
AF:
0.659
TwinsUK
AF:
0.809
AC:
2998
ALSPAC
AF:
0.811
AC:
3126
ESP6500AA
AF:
0.374
AC:
1404
ESP6500EA
AF:
0.814
AC:
6685
ExAC
AF:
0.770
AC:
93070
Asia WGS
AF:
0.745
AC:
2587
AN:
3478
EpiCase
AF:
0.796
EpiControl
AF:
0.798

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephaly 1, primary, autosomal recessive Benign:4Other:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.22
T;.;.
Eigen
Benign
-0.080
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.17
N
MetaRNN
Benign
8.9e-7
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;M;.
PhyloP100
0.26
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-2.3
N;D;N
REVEL
Benign
0.085
Sift
Benign
0.056
T;D;D
Sift4G
Uncertain
0.030
D;T;T
Polyphen
1.0
D;.;.
Vest4
0.051
ClinPred
0.020
T
GERP RS
2.7
Varity_R
0.082
gMVP
0.22
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs930557; hg19: chr8-6302183; COSMIC: COSV60915866; API